Antibiotic Stewardship Program Not Followed
Summary
The facility did not implement its antibiotic stewardship program to ensure accurate antibiotic use for four sampled residents. The facility’s policy, revised 5/29/24, states the Infection Preventionist is to track antibiotic starts, monitor adherence to evidence-based criteria during evaluation and management of treated infections, and review clinical justification for continued antibiotic use beyond the initial ordered duration, including review of laboratory reports and cultures. R13 had diagnoses including osteomyelitis of the vertebra, lymphedema, and MRSA infection, and had intact cognition. The record showed Loeb’s criteria for a UTI on a surveillance line list with a date of infection of 10/21/25, but the form indicated R13 did not meet Loeb criteria for a UTI without an indwelling catheter and no culture or signs/symptoms of UTI were identified. Despite this, R13 received Levaquin/linezolid for a UTI, and the facility did not update the physician that R13 did not meet criteria for infection and antibiotic use. DON-B stated the provider should have been contacted to determine whether antibiotic therapy should have been continued when R13 returned from the hospital. R9, who had diagnoses including spastic quadriplegic cerebral palsy, depression, anxiety, and obstructive and reflux uropathy, also had intact cognition. The Loeb’s criteria form for UTI indicated R9 met criteria on 11/3/25, but the required culture was not attached, and the hospital culture later showed normal flora. R9 was started on Levaquin for UTI treatment while the pathogen was pending, and DON-B confirmed R9 did not meet criteria for antibiotic treatment. R11, who had Alzheimer’s disease, chronic kidney disease, and acute and chronic respiratory failure, was documented as being treated prophylactically for chest with doxycycline and as meeting Loeb’s criteria for a respiratory infection, but review showed R11 did not meet criteria for antibiotic therapy; DON-B noted chest X-rays did not show a new infiltrate and the signs and symptoms identified were not on the Loeb criteria form. R2, who had bilateral primary osteoarthritis of the knee, lymphedema, and cellulitis to both lower limbs, had an order for cefdinir 300 mg twice daily with an indication of sepsis of knee/prophylaxis, but the record did not include a duration or periodic re-evaluation plan, and the prophylactic antibiotic was not routinely assessed for continued use.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.